Lobbying Information
Subject Matters
- Government Procurement
- Health
- Research and Development
- Science and Technology
Subject Matter Details
Policies or Program
- Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology
- Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models
- The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Federal Economic Development Agency for Southern Ontario (FedDev)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Innovation, Science and Economic Development Canada (ISED)
-
Public Health Agency of Canada (PHAC)
-
Public Services and Procurement Canada (PSPC)
-
Treasury Board Of Canada Secretariat (TBS)
Government institutions added through a monthly communication report
- Privy Council Office (PCO)
In-house Corporation Details
Description of activities
Moderna is an American biotech company focusing on vaccine technologies. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured.
Responsible officer name and position during the period of this registration
Patricia Gauthier,
General Manager, Canada
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
666 Burrard Street
Suite 1700, Park Place
Vancouver, BC V6C 2X8
Canada
Telephone number:
416-859-0079
Parent Company Information
- Moderna TX, Inc.
-
200 Technology Drive
Cambridge, MA 02139
United States of America
Subsidiary Beneficiary Information
Moderna Biopharma Canada Corporation does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Patricia Gauthier,
General Manager, Canada |
No public offices held
- Shehzad Iqbal,
Sr. Medical Director |
No public offices held
- Kavisha Jayasundara,
Director, Market Access and Innovative Partnerships |
No public offices held
- Leslie Madden,
Sr. Director, Regulatory Science and Quality Assurance |
No public offices held
- Stefan Raos,
Director, Market Access and Innovative Partnerships |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
No lobbyists added
